Natixis Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $55.9M | Sell |
2,319,414
-394,139
| -15% | -$10.3M | 0.06% | 281 |
|
|
2026
Q1 | $76.2M | Buy |
2,713,553
+508,278
| +23% | +$13.5M | 0.11% | 191 |
|
|
2025
Q4 | $54.9M | Buy |
2,205,275
+476,073
| +28% | +$12M | 0.08% | 243 |
|
|
2025
Q3 | $44.1M | Sell |
1,729,202
-522,523
| -23% | -$12.9M | 0.06% | 278 |
|
|
2025
Q2 | $54.6M | Sell |
2,251,725
-290,771
| -11% | -$6.78M | 0.09% | 233 |
|
|
2025
Q1 | $64.4M | Buy |
2,542,496
+318,688
| +14% | +$8.34M | 0.12% | 187 |
|
|
2024
Q4 | $59M | Sell |
2,223,808
-174,092
| -7% | -$4.72M | 0.11% | 188 |
|
|
2024
Q3 | $69.4M | Sell |
2,397,900
-203,516
| -8% | -$5.94M | 0.14% | 160 |
|
|
2024
Q2 | $72.8M | Buy |
2,601,416
+387,856
| +18% | +$10.7M | 0.16% | 139 |
|
|
2024
Q1 | $61.4M | Buy |
2,213,560
+980,321
| +79% | +$27.2M | 0.14% | 163 |
|
|
2023
Q4 | $35.5M | Sell |
1,233,239
-157,733
| -11% | -$4.77M | 0.09% | 229 |
|
|
2023
Q3 | $46.1M | Sell |
1,390,972
-1,061,722
| -43% | -$37.5M | 0.14% | 159 |
|
|
2023
Q2 | $90M | Buy |
2,452,694
+1,232,948
| +101% | +$48M | 0.28% | 86 |
|
|
2023
Q1 | $49.8M | Sell |
1,219,746
-927,861
| -43% | -$40.1M | 0.17% | 143 |
|
|
2022
Q4 | $110M | Buy |
2,147,607
+816,561
| +61% | +$39.1M | 0.42% | 54 |
|
|
2022
Q3 | $58.2M | Sell |
1,331,046
-317,452
| -19% | -$15.4M | 0.25% | 105 |
|
|
2022
Q2 | $86.4M | Buy |
1,648,498
+50,997
| +3% | +$2.6M | 0.38% | 61 |
|
|
2022
Q1 | $82.7M | Buy |
1,597,501
+478,224
| +43% | +$24.8M | 0.32% | 71 |
|
|
2021
Q4 | $66.1M | Buy |
1,119,277
+253,047
| +29% | +$12.5M | 0.25% | 93 |
|
|
2021
Q3 | $37.3M | Buy |
866,230
+6,647
| +0.8% | +$294K | 0.15% | 153 |
|
|
2021
Q2 | $33.7M | Buy |
859,583
+65,556
| +8% | +$2.55M | 0.16% | 161 |
|
|
2021
Q1 | $28.8M | Sell |
794,027
-49,574
| -6% | -$1.76M | 0.15% | 169 |
|
|
2020
Q4 | $31.1M | Sell |
843,601
-236,315
| -22% | -$8.67M | 0.18% | 138 |
|
|
2020
Q3 | $37.6M | Sell |
1,079,916
-171,486
| -14% | -$6.01M | 0.24% | 98 |
|
|
2020
Q2 | $38.8M | Sell |
1,251,402
-28,728
| -2% | -$976K | 0.26% | 82 |
|
|
2020
Q1 | $39.6M | Sell |
1,280,130
-209,899
| -14% | -$7.15M | 0.32% | 68 |
|
|
2019
Q4 | $55.4M | Buy |
1,490,029
+261,612
| +21% | +$9.32M | 0.39% | 54 |
|
|
2019
Q3 | $41.9M | Sell |
1,228,417
-178,291
| -13% | -$6.48M | 0.33% | 64 |
|
|
2019
Q2 | $57.8M | Sell |
1,406,708
-24,194
| -2% | -$961K | 0.47% | 46 |
|
|
2019
Q1 | $57.7M | Sell |
1,430,902
-106,301
| -7% | -$4.26M | 0.5% | 41 |
|
|
2018
Q4 | $63.7M | Buy |
1,537,203
+22,808
| +2% | +$947K | 0.63% | 33 |
|
|
2018
Q3 | $63.3M | Sell |
1,514,395
-138,466
| -8% | -$5.33M | 0.56% | 36 |
|
|
2018
Q2 | $56.9M | Buy |
1,652,861
+71,396
| +5% | +$2.44M | 0.54% | 32 |
|
|
2018
Q1 | $53.3M | Buy |
1,581,465
+42,955
| +3% | +$1.48M | 0.53% | 32 |
|
|
2017
Q4 | $52.9M | Buy |
1,538,510
+20,714
| +1% | +$706K | 0.54% | 34 |
|
|
2017
Q3 | $51.4M | Buy |
1,517,796
+61,398
| +4% | +$1.97M | 0.54% | 34 |
|
|
2017
Q2 | $46.4M | Buy |
1,456,398
+52,691
| +4% | +$1.66M | 0.5% | 39 |
|
|
2017
Q1 | $45.6M | Buy |
1,403,707
+116,826
| +9% | +$3.68M | 0.5% | 41 |
|
|
2016
Q4 | $39.7M | Buy |
1,286,881
+134,941
| +12% | +$4.12M | 0.48% | 41 |
|
|
2016
Q3 | $37M | Buy |
1,151,940
+120,164
| +12% | +$4.02M | 0.48% | 40 |
|
|
2016
Q2 | $34.5M | Buy |
1,031,776
+41,014
| +4% | +$1.31M | 0.48% | 37 |
|
|
2016
Q1 | $27.9M | Buy |
990,762
+121,520
| +14% | +$3.47M | 0.42% | 43 |
|
|
2015
Q4 | $26.6M | Buy |
869,242
+22,247
| +3% | +$700K | 0.44% | 38 |
|
|
2015
Q3 | $25.2M | Buy |
846,995
+38,986
| +5% | +$1.25M | 0.44% | 35 |
|
|
2015
Q2 | $25.7M | Buy |
808,009
+65,997
| +9% | +$2.15M | 0.44% | 31 |
|
|
2015
Q1 | $24.5M | Buy |
742,012
+37,406
| +5% | +$1.19M | 0.43% | 29 |
|
|
2014
Q4 | $20.8M | Sell |
704,606
-12,986
| -2% | -$372K | 0.39% | 35 |
|
|
2014
Q3 | $20.1M | Sell |
717,592
-55,269
| -7% | -$1.55M | 0.4% | 33 |
|
|
2014
Q2 | $21.8M | Sell |
772,861
-33,266
| -4% | -$948K | 0.31% | 51 |
|
|
2014
Q1 | $24.6M | Buy |
806,127
+29,351
| +4% | +$875K | 0.38% | 31 |
|
|
2013
Q4 | $22.6M | Buy |
776,776
+30,721
| +4% | +$894K | 0.37% | 34 |
|
|
2013
Q3 | $20.3M | Buy |
746,055
+112,340
| +18% | +$3.06M | 0.37% | 34 |
|
|
2013
Q2 | $16.8M | Buy |
+633,715
| New | +$17.5M | 0.34% | 45 |
|
Other funds holding PFE
Natixis Advisors's PFE Position: Q2 2026 in Review
Natixis Advisors reduced its Pfizer (PFE) stake by 15% in Q2 2026, selling an estimated $10.3M and leaving 2,319,414 shares worth $55.9M. The position accounts for 0.06% of the portfolio, ranked #281.
Natixis Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $110M in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Natixis Advisors held 2,319,414 shares of Pfizer worth $55.9M as of Q2 2026.
- Natixis Advisors sold 394,139 Pfizer shares in Q2 2026, an estimated $10.3M.
- Pfizer made up 0.06% of Natixis Advisors's portfolio in Q2 2026, its #281 holding.
- Natixis Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Natixis Advisors's Pfizer position peaked at $110M in Q4 2022.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.